neurological microbiome program
Multiple Sclerosism (MS)
MS is a chronic immune‑mediated disease where the body attacks the myelin coating of nerves in the brain and spinal cord.
Overview
Multiple Sclerosis (MS) is a chronic immune‑mediated disease where the body attacks the myelin coating of nerves in the brain and spinal cord. It often starts in early adulthood and can cause episodes (relapses) or gradual progression. Symptoms vary widely—vision problems, numbness, weakness, fatigue, balance issues. Early treatment reduces relapse risk and long‑term disability.
Common Misunderstandings
MS is not “all in the mind,” and it isn’t predictable. People often face uncertainty, fatigue others can’tsee, and shifting symptoms. Many try diet changes or supplements without guidance, which can be exhausting and confusing.
How is Multiple Sclerosis Linked to Your Microbiome?
- Reviews in leading journals show consistent alterations in gut microbiome composition in MS versus controls, with shifts in bacteria that regulate immune responses (e.g., T‑cells, B‑cells). Dysbiosis is considered a contributor that can modulate disease activity. Nature
- Causality signals: gut microbiota from people with MS can transfer susceptibility to MS‑like disease when transplanted into germ‑free mice, suggesting microbial communities can influence autoimmunity. PNAS
- Short‑chain fatty acids (SCFAs) such as propionate—made by fibre‑fermenting gut bacteria—appear reduced in MS; adjunct propionic acid has shown immune and clinical benefits in early studies. Mechanistic and clinical work is ongoing. CellOxford Academic
Been diagnosed with Multiple Sclerosis?
Addressing the microbiome might help you.
The Microbiome Clinic™ offers thorough testing and tailored microbiome treatment plans grounded in science.
